Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PRME Prime Medicine, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $3.20 +6.7% | $15.37 -0.2% |
| StockIQ Score | 37F Weak Risk: High | 35F Weak Risk: High |
| Technical | 29F | 13F |
| Fundamental | 30F | 35F |
| Growth | 51C- | 50C- |
| Fair Value | 38F | 38F |
| News | 44D | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Prime Medicine (PRME) outperforms Ascentage Pharma (AAPG) in technicals and investor sentiment, with scores of 77 versus 18 in technicals and 49 versus 37 in investor confidence. Both have similar valuation scores at 38, but PRME’s moderate rating contrasts with AAPG’s weak rating. Growth scores are nearly equal, with PRME slightly ahead at 51.